Sheng‐Shun Yang

6.1k total citations
149 papers, 3.2k citations indexed

About

Sheng‐Shun Yang is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sheng‐Shun Yang has authored 149 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Hepatology, 80 papers in Epidemiology and 32 papers in Surgery. Recurrent topics in Sheng‐Shun Yang's work include Hepatitis C virus research (68 papers), Liver Disease Diagnosis and Treatment (60 papers) and Hepatitis B Virus Studies (56 papers). Sheng‐Shun Yang is often cited by papers focused on Hepatitis C virus research (68 papers), Liver Disease Diagnosis and Treatment (60 papers) and Hepatitis B Virus Studies (56 papers). Sheng‐Shun Yang collaborates with scholars based in Taiwan, United States and China. Sheng‐Shun Yang's co-authors include Ding‐Shinn Chen, Chun‐Jen Liu, Chi‐Sen Chang, Jia‐Horng Kao, Shou‐Wu Lee, Gran‐Hum Chen, Hong‐Zen Yeh, Chien‐Jen Chen, Chuan–Mo Lee and Pei‐Jer Chen and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Sheng‐Shun Yang

141 papers receiving 3.1k citations

Peers

Sheng‐Shun Yang
Kwan Soo Byun South Korea
Young Seok Kim South Korea
Hyung Joon Yim South Korea
Ivo Ditah United States
Young Kul Jung South Korea
Yeon Seok Seo South Korea
Kwan Soo Byun South Korea
Sheng‐Shun Yang
Citations per year, relative to Sheng‐Shun Yang Sheng‐Shun Yang (= 1×) peers Kwan Soo Byun

Countries citing papers authored by Sheng‐Shun Yang

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Shun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Shun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Shun Yang more than expected).

Fields of papers citing papers by Sheng‐Shun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Shun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Shun Yang. The network helps show where Sheng‐Shun Yang may publish in the future.

Co-authorship network of co-authors of Sheng‐Shun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Shun Yang. A scholar is included among the top collaborators of Sheng‐Shun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Shun Yang. Sheng‐Shun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.
2.
Yang, Sheng‐Shun, et al.. (2025). Predicting Neoplastic Polyp in Patients With Gallbladder Polyps Using Interpretable Machine Learning Models: Retrospective Cohort Study. Cancer Medicine. 14(5). e70739–e70739. 2 indexed citations
3.
Su, Tung‐Hung, Sheng‐Shun Yang, Mei–Hsuan Lee, et al.. (2025). High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 31(3). 796–809. 1 indexed citations
5.
Liao, Yijun, et al.. (2024). Impact of Duodenal Papilla Morphology on the Success of Transpancreatic Precut Sphincterotomy. Journal of Clinical Medicine. 13(22). 6940–6940. 1 indexed citations
7.
Fu, Jachih, Chen‐Chi Wang, Chun‐Yi Chuang, et al.. (2023). A cascade deep learning model for diagnosing pharyngeal acid reflux episodes using hypopharyngeal multichannel intraluminal Impedance-pH signals. Intelligence-Based Medicine. 8. 100131–100131. 2 indexed citations
8.
Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations
10.
Hong, Chun‐Ming, Chun‐Jen Liu, Shiou‐Hwei Yeh, et al.. (2021). Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses. 13(11). 2294–2294. 1 indexed citations
11.
Yang, Sheng‐Shun, Tung‐Hung Su, Hung‐Chih Yang, et al.. (2018). Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Journal of Hepatology. 68. S266–S266. 5 indexed citations
12.
Lee, Shou‐Wu, et al.. (2018). The prevalence and risk factors of hepatitis B flares in chronic hepatitis B patients receiving glucocorticoid pulse therapy. International Journal of Clinical Pharmacy. 40(1). 169–174. 6 indexed citations
13.
Lee, Shou‐Wu, Teng‐Yu Lee, Sheng‐Shun Yang, Hong‐Zen Yeh, & Chi‐Sen Chang. (2016). Two-year Single-Center Real-Life Data of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B Patients in Taiwan. Journal of Gastroenterology and Hepatology Research. 5(2). 2010–2014.
14.
Liu, Chen‐Hua, Chung‐Feng Huang, Chun‐Jen Liu, et al.. (2015). Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial. Scientific Reports. 5(1). 11710–11710. 7 indexed citations
15.
Wang, Chia‐Chi, Chih‐Lin Lin, Kuo‐Chih Tseng, et al.. (2015). Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. Hepatology International. 10(2). 294–301. 3 indexed citations
16.
Lee, Shou‐Wu, Teng‐Yu Lee, Han‐Chung Lien, et al.. (2014). Characteristics of Symptom Presentation and Risk Factors in Patients with Erosive Esophagitis and Nonerosive Reflux Disease. Medical Principles and Practice. 23(5). 460–464. 8 indexed citations
17.
Chang, Shu‐Chuan, et al.. (2013). Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study. Journal of the Formosan Medical Association. 114(9). 829–834. 3 indexed citations
18.
Lee, Shou‐Wu, Han‐Chung Lien, Chi-Sen Chang, et al.. (2012). The Comparison of Biopsy Sites Measured by Rapid Urease Test for Diagnosed of Helicobacter pylori Infection Between a Population with Gastric and Duodenal Ulcers. Journal of Gastroenterology and Hepatology Research. 1(9). 226–229. 1 indexed citations
19.
Lu, Sheng‐Nan, Wei‐Wen Su, Sheng‐Shun Yang, et al.. (2006). Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan. International Journal of Cancer. 119(8). 1946–1952. 111 indexed citations
20.
Yeh, Hong‐Zen, et al.. (2003). Long‐term follow up of gastric low‐grade mucosa‐associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. Journal of Gastroenterology and Hepatology. 18(2). 162–167. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026